ADMA Biologics Inc vs iShares MSCI Germany (DAX) — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while iShares MSCI Germany (DAX) trades at $43.99. The key difference: iShares MSCI Germany (DAX) is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | EWG | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $20.38 | $44.56 |
52-Week Low | $7.60 | $38.08 |
Enterprise Value | $2.29B | — |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →